When a baby is born, hospital staff move quickly through a standard checklist of newborn care: taking measurements, ...
Phase 3 VIKTORIA-1 trial achieved primary endpoint with clinically meaningful improvement in progression-free survival in PIK3CA mutant cohort; detailed data for gedatolisib regimens will be presented ...
Phase 1b Registrational Clinical Study of SER-252 Underway in Advanced Parkinson's Disease; TFL data from the SAD study arm targeted for first half of 2027 - - Closed $21.2 million private placement ...
Roche launched Tecentriq SC in India, reducing lung cancer immunotherapy delivery time from hours to just seven minutes.
Patients were safely able to return home and receive the diuretic by minipump, minimizing their time spent at the hospital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results